Longeveron, Inc. (LGVN)
1.71
-0.07
(-3.93%)
USD |
NASDAQ |
Nov 05, 16:00
Longeveron Market Cap : 5.424M for Nov. 5, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 5.424M |
| November 04, 2026 | 5.646M |
| November 03, 2026 | 5.646M |
| November 02, 2026 | 5.424M |
| October 30, 2026 | 5.297M |
| October 29, 2026 | 5.551M |
| October 28, 2026 | 5.646M |
| October 27, 2026 | 5.487M |
| October 26, 2026 | 5.091M |
| October 23, 2026 | 5.075M |
| October 22, 2026 | 5.043M |
| October 21, 2026 | 4.536M |
| October 20, 2026 | 4.758M |
| October 19, 2026 | 4.409M |
| October 16, 2026 | 4.409M |
| October 15, 2026 | 4.758M |
| October 14, 2026 | 5.487M |
| October 13, 2026 | 6.820M |
| October 12, 2026 | 7.771M |
| October 09, 2026 | 7.866M |
| October 08, 2026 | 7.517M |
| October 07, 2026 | 7.739M |
| October 06, 2026 | 7.454M |
| October 05, 2026 | 7.962M |
| October 02, 2026 | 8.184M |
| Date | Value |
|---|---|
| October 01, 2026 | 8.215M |
| September 30, 2026 | 8.532M |
| September 29, 2026 | 8.628M |
| September 28, 2026 | 8.342M |
| September 25, 2026 | 8.913M |
| September 24, 2026 | 9.230M |
| September 23, 2026 | 8.247M |
| September 22, 2026 | 8.628M |
| September 21, 2026 | 7.771M |
| September 18, 2026 | 7.898M |
| September 17, 2026 | 8.596M |
| September 16, 2026 | 21.19M |
| September 15, 2026 | 21.76M |
| September 14, 2026 | 21.95M |
| September 11, 2026 | 23.25M |
| September 10, 2026 | 21.06M |
| September 09, 2026 | 20.87M |
| September 08, 2026 | 21.09M |
| September 04, 2026 | 21.60M |
| September 03, 2026 | 20.87M |
| September 02, 2026 | 21.51M |
| September 01, 2026 | 21.41M |
| August 31, 2026 | 21.89M |
| August 28, 2026 | 21.32M |
| August 27, 2026 | 21.57M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.110B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.860B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| PS Ratio | 3.510 |
| Price to Book Value | 0.5214 |
| Price | 1.71 |
| Earnings Yield | -593.6% |